¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"È¿"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
oxalic fermentation
¿Á»ì»ê¹ßÈ¿
oxidase
»êÈÈ¿¼Ò
oxidase reaction
»êÈÈ¿¼Ò¹ÝÀÀ
oxidation-fermentation medium
»êȹßÈ¿¹èÁö
oxidative enzyme
»êÈÈ¿¼Ò
oxidative fermentation
»êȹßÈ¿
oxidoreductase
»êÈȯ¿øÈ¿¼Ò
oxygen enhancement ratio
»ê¼ÒÈ¿°úÁõ°·ü, »ê¼ÒÁõ°ºñ
phase shift effect
À§»óº¯À§È¿°ú
phosphatase
ÀλêºÐÇØÈ¿¼Ò
phosphoglucoisomerase
ÀλêÆ÷µµ´çÀ̼ºÈÈ¿¼Ò
phosphorylase
ÀλêÈÈ¿¼Ò
phosphorylating enzyme
ÀλêÈÈ¿¼Ò
photochemical effect
±¤ÈÇÐÈ¿°ú
photoconductive effect
±¤ÀüµµÈ¿°ú
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
gradient moment nulling
±â¿ï±â¸ð¸àÆ®¹«È¿È
hemopexin
ÀÀÇ÷È¿¼Ò
heparinase
ÇìÆÄ¸°ºÐÇØÈ¿¼Ò
heterofermentation
ÀÌÇü¹ßÈ¿
holoenzyme
¿ÏÀüÈ¿¼Ò
homofermentation
µ¿Á¾¹ßÈ¿
hyaluronidase
È÷¾Ë·ç·Ð»êºÐÇØÈ¿¼Ò
hydrogenase
¼ö¼ÒÈÈ¿¼Ò
hydroperoxidase
È÷µå·Î°ú»êÈÈ¿¼Ò
hydroxybutyrate dehydrogenase
¼ö»êÈºÎÆ¼·¹ÀÌÆ®Å»¼ö¼ÒÈ¿¼Ò
hydroxylase
¼ö»êÈÈ¿¼Ò
horseradish peroxidase
È«´ç¹«°ú»êÈÈ¿¼Ò
insulinase
Àν¶¸°ºÐÇØÈ¿¼Ò
invertase
¿ªÀüÈ¿¼Ò
isoamylase
µ¿À§ÀüºÐºÐÇØÈ¿¼Ò
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
plasmacoagulase
Ç÷ÀåÀÀ°íÈ¿¼Ò.
plasmin
ÇöóÁî¹Î, ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò(àéë«áÈéÁ ú°ý£
plasmin
Çö󽺹Î, ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò(àéë«áÈéÁú°ý£áÈ)
plateau effect
°íÆòºÎÈ¿°ú(¡üùÍý).
plating efficiency
ÆòÆÇ¹è¾ç Áõ½ÄÈ¿À²
plating efficiency
ÆòÆÇ¹è¾çÈ¿À²
polarity effect
±Ø¼ºÈ¿°ú
polarizing effect
ºÐ±ØÈ¿°ú(¡üùÍý).
polymerase
ÁßÇÕÈ¿¼Ò, Æú¸®¸Ó·¹À̽º.
polymerase
ÁßÇÕÈ¿¼Ò
polymerase chain reaction
ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
polymerase chain reaction
ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ
polymerase chain reaction
Á¾ÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
polymerase chain reaction (PCR)
ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
polymerase chain reaction=PCR
ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
effective renal blood flow =ERBF
À¯È¿½ÅÇ÷·ù·®(êóüùãìúì×µÕá).
effective renal blood flow =ERBF
À¯È¿½ÅÇ÷·ù·®.
effective renal plasma flow
À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
effective renal plasma flow =ERPF
À¯È¿½ÅÇ÷Àå·ù·®(êóüùãìúìíì×µÕá).
effective renal plasma flow =ERPF
À¯È¿½ÅÇ÷Àå·ù·®.
effective stack height
À¯È¿±¼¶Ò³ôÀÌ.
effective temperature
°¨°¢¿Âµµ, À¯È¿¿Âµµ.
effective temperature index
À¯È¿¿ÂµµÁö¼ö.
effective value
½ÇÈ¿°ª, À¯È¿°ª.
effective voltage
¹æ»ç ÇÙÀÇÀ¯È¿Àü¾Ð.
effective wave length
½ÇÈ¿ÆÄÀå.
effective wavelength
À¯È¿ÆÄÀå
effectiveness
È¿°ú.
effector
È¿°ú±â
effector
È¿°ú±â
ÀÌÀü
´ÙÀ½
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
synthase
"½ÅÅ×À̽º, ÇÕ¼ºÈ¿¼Ò(ùêà÷ý£áÈ)"
synthetase
"½ÅÅ×Å×À̽º, ÇÕ¼ºÈ¿¼Ò(ùêà÷ý£áÈ)"
terminal enzyme
¸»´ÜÈ¿¼Ò (ØÇÓ®ý£áÈ)
thermostable enzyme
¿¾ÈÁ¤È¿¼Ò (æðäÌïÒý£áÈ)
thiol enzyme
ŸÀ̿à ȿ¼Ò(ý£áÈ)
thyrotoxic effect
°©»ó¼±Áßµ¶ È¿°ú (Ë£ßÒàÍñéÔ¸üùÍý)
time factor effect
½Ã°£ÀÎÀÚ È¿°ú (ãÁÊàì×íüùÍý)
tissue-specific enzyme
Á¶Á÷ ƯÀÌ È¿¼Ò (ðÚòÄ÷åì¶ý£áÈ)
trans effect
Æ®¶õ½º È¿°ú(üùÍý)
Tyndall effect
ƾ´Þ È¿°ú(üùÍý)
uncoating enzyme
¿ÜÇÇÁ¦°Å(èâù«ð¶ËÛ) È¿¼Ò (ý£áÈ)
untwisting enzyme
²¿ÀÓÇ®±â È¿¼Ò (ý£áÈ)
ur enzyme
¿øÈ¿¼Ò(ê«ý£áÈ)
uridine nucleotide coenzyme
À¯¸®µò ´©Å¬·¹¿ÀŸÀÌµå º¸È¿¼Ò(ÜÍý£áÈ)
vectorial enzyme
ÁöÇâ(ò¦ú¾) È¿¼Ò(ý£áÈ)
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
6
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
¼³¸í
zymolite µ¿ÀǾî=substrate.
zymologist
È¿¼ÒÇÐÀÚ
zymolysis
¹ßÈ¿ÀÛ¿ë
zymonematosis
È¿¸ðÁõ, ºÐ¾Æ±ÕÁõ
zymophore group
È¿¼ÒÀÛ¿ëÁ·
zymosis
¹ßÈ¿, È¿¼ºº´, Àü¿°º´
zymotechnic
¹ßÈ¿ÇÐ
ÀÌÀü
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
marginal utility
ÇѰè È¿¿ë
medicative
¾àÈ¿°¡ ÀÖ´Â
medicinal
ÀǾàÀÇ;¾àÈ¿°¡ ÀÖ´Â
merchandising
»óÇ°È °èȹ;È¿°úÀû ÆÇ¸Å ÃËÁøÃ¥
metalloenzyme
±Ý¼Ó È¿¼Ò
methicillin
¸ÞƼ½Ç¸°(Æ÷µµ»ó ±¸±Õ¿¡ È¿°ú°¡ ÀÖ´Â ÇÕ¼º Æä´Ï½Ç¸°)
microzyme
È¿¸ð±Õ;¹ßÈ¿ ¹Ì»ý¹°
millirem
¹æ»ç¼±ÀÇ »ýü ½ÇÈ¿ ¼±·®´ÜÀ§;1·½ÀÇ ÃµºÐÀÇ 1
miracle drug
Ưȿ¾à;¿µ¾à
mistrial
¿ÀÆÇ;¹«È¿½É¸®(ÀýÂ÷»ó °ú¿À¿¡ ÀÇÇÑ)
near miss
(À¯È¿ÇÑ)±ÙÁ¢Æø°Ý(»ç°Ý);Áö±Ùź;(°ø)(ºñÇà±âÀÇ)ÀÌ»óÁ¢±Ù;´Ï¾î¹Ì½º;¼º°ø¿¡ °¡°¡¿î°Í;ÀϺ¸Á÷Àü(ÀÇ ¼º°ú)
needfire
Á¤È;(³ª¹«¸¦ ¸¶ÂûÇØ¼ ÀÏÀ¸Å² ºÒ,°¡Ãິ¿¡ Ưȿ°¡ ÀÖ´Ù°í ¹Ï¾îÁ³À½);ºÀÈ;ȶºÒ;ÀÚ¿¬¹ßÈ;(½âÀº ³ª¹«µîÀÇ)¹ß±¤
negate
(»ç½Ç,Áø½ÇÀ»)ºÎÁ¤(ºÎÀÎ)ÇÏ´Ù(deny);Ãë¼ÒÇÏ´Ù;¹«È¿·Î ÇÏ´Ù;ºÎÁ¤(¹Ý´ë)ÀûÀÎ °Í
negative
ºÎÁ¤(ºÎÀÎ)ÀÇ;ºÎÁ¤ÀûÀÎ;°ÅºÎÀûÀÎ;¹Ý´ëÀÇ;Àû±Ø¼ºÀÌ ¾ø´Â;¼Ò±ØÀûÀÎ;È¿°ú°¡ ¾ø´Â;¾µ¸ð¾ø´Â;À½ÀÇ ¸¶À̳ʽºÀÇ;À½¼ºÀÇ;À½Àü±âÀÇ(¸¦ ÀÏÀ¸Å°´Â);À½ÈÀÇ
negative
°ÅºÎ(°ÅÀý)ÇÏ´Ù;ºÎÀÎ(ºÎÁ¤)ÇÏ´Ù;ºÎ°áÇÏ´Ù;³í¹ÚÇÏ´Ù;¹ÝÁõÇÏ´Ù;¹«È¿·ÎÇÏ´Ù;ÁßÈÇÏ´Ù;negativeness()n
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½